Background: The HIV-2 env’s 3 ’ end encodes the cytoplasmic tail (CT) of the Env protein. This genomic region also encodes the rev, Tat and Nef protein in overlapping reading frames. We studied the variability in the CT coding region in 46 clinical specimens and in 2 reference strains by sequencing and by culturing. The aims were to analyse the variability of Env CT and the evolution of proteins expressed from overlapping coding sequences. Results: A 70 % reduction of the length of the CT region affected the HIV-2 ROD and EHO strains in vitro due to a premature stop codon in the env gene. In clinical samples this wasn’t observed, but the CT length varied due to insertions and deletions. We noted 3 conserved and 3 variable regions in the CT....
Substantial controversy surrounds the membrane topology of the HIV-1 gp41 C-terminal tail (CTT). Whi...
The V3 loop of the HIV-1 Env protein is the primary determinant of viral coreceptor usage, whereas t...
Background: The development of a vaccine against HIV/AIDS capable of preventing virus infection has ...
Background: The HIV-2 env's 3′ end encodes the cytoplasmic tail (CT) of the Env protein. This genomi...
The HIV-2 env’s 3’ end encodes the cytoplasmic tail (CT) of the Env protein. This genomic region als...
AbstractThis study focuses on the long stretch of highly conserved amino acids in the membrane proxi...
AbstractEmploying antibodies against the cytoplasmic tail of the HIV-1 glycoprotein (Env-CT), in add...
Abstract publicado em: International Journal of Infectious Diseases. 2010;14(Supl 1).Background: Hu...
The cytoplasmic tail (CT) of the HIV-2 envelope glycoprotein (Env) includes amino acid (aa) sequence...
AbstractSIVmac239 and SIVmac1A11 are wild-type viruses encoding Env proteins with full-length or tru...
<p>Above each plot are shown key regions of the different proteins. The <i>tat</i> 2<sup>nd</sup> ex...
In-frame stop codons were introduced into the coding region of human immunodeficiency virus type 1 (...
Limited data are available on the pathogenesis of HIV-2, and the evolution of Env molecular properti...
Substantial controversy surrounds the membrane topology of the HIV-1 gp41 C-terminal tail (CTT). Whi...
Additional file 2: Fig. S1. Domains and endocytosis signals in JRFL, JRCSF, 4-2.J41 and A5. (a) Sequ...
Substantial controversy surrounds the membrane topology of the HIV-1 gp41 C-terminal tail (CTT). Whi...
The V3 loop of the HIV-1 Env protein is the primary determinant of viral coreceptor usage, whereas t...
Background: The development of a vaccine against HIV/AIDS capable of preventing virus infection has ...
Background: The HIV-2 env's 3′ end encodes the cytoplasmic tail (CT) of the Env protein. This genomi...
The HIV-2 env’s 3’ end encodes the cytoplasmic tail (CT) of the Env protein. This genomic region als...
AbstractThis study focuses on the long stretch of highly conserved amino acids in the membrane proxi...
AbstractEmploying antibodies against the cytoplasmic tail of the HIV-1 glycoprotein (Env-CT), in add...
Abstract publicado em: International Journal of Infectious Diseases. 2010;14(Supl 1).Background: Hu...
The cytoplasmic tail (CT) of the HIV-2 envelope glycoprotein (Env) includes amino acid (aa) sequence...
AbstractSIVmac239 and SIVmac1A11 are wild-type viruses encoding Env proteins with full-length or tru...
<p>Above each plot are shown key regions of the different proteins. The <i>tat</i> 2<sup>nd</sup> ex...
In-frame stop codons were introduced into the coding region of human immunodeficiency virus type 1 (...
Limited data are available on the pathogenesis of HIV-2, and the evolution of Env molecular properti...
Substantial controversy surrounds the membrane topology of the HIV-1 gp41 C-terminal tail (CTT). Whi...
Additional file 2: Fig. S1. Domains and endocytosis signals in JRFL, JRCSF, 4-2.J41 and A5. (a) Sequ...
Substantial controversy surrounds the membrane topology of the HIV-1 gp41 C-terminal tail (CTT). Whi...
The V3 loop of the HIV-1 Env protein is the primary determinant of viral coreceptor usage, whereas t...
Background: The development of a vaccine against HIV/AIDS capable of preventing virus infection has ...